Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00590330 · ClinicalTrials.gov registry record

Microbial Community Composition and Dynamics in Lungs of Cystic Fibrosis Sibling Pairs

A clinical trial, sponsored by Boston Children's Hospital.

Completed
Registry status
55
Enrollment target

NCT00590330 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 55 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00590330 has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
55 participants
Enrollment target

Study Summary

The purpose of this study is to identify all the bacterial species present in the respiratory tracts of patients with Cystic Fibrosis (CF), and to connect them with clinical information. Traditional culture methods of throat swab and sputum samples can only identify the most prevalent bacteria in samples, those of which there are over about 5 million bacteria per teaspoon. A recently developed method has been found to be more sensitive and can detect up to several hundred bacterial species in throat swab or sputum sample of individual CF patients.

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2007-10
Est. Completion 2009-03

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT00590330

The ClinicalTrials.gov registry entry for NCT00590330 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00590330 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00590330 about?

NCT00590330 is a clinical study titled "Microbial Community Composition and Dynamics in Lungs of Cystic Fibrosis Sibling Pairs". The purpose of this study is to identify all the bacterial species present in the respiratory tracts of patients with Cystic Fibrosis (CF), and to connect them with clinical information. Traditional culture methods of throat swab and sputum samples can only identify the most prevalent bacteria in sa...

What is the current status of trial NCT00590330?

This trial is currently completed. The enrollment target is 55 participants. The study started on 2007-10. Estimated completion is 2009-03.

Who is sponsoring clinical trial NCT00590330?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.